PI3K/AKT/mTOR通路
个性化医疗
医学
人口
优先次序
蛋白激酶B
临床终点
癌症研究
肿瘤科
临床试验
生物信息学
生物
内科学
信号转导
遗传学
环境卫生
经济
管理科学
作者
Xudong Mao,Zhehao Xu,Xiaoping Yang,Shihan Chen,Liyang Li,Zeyi Lu,Haohua Lu,Yudong Lin,Ruyue Wang,Yang Li,Fan Li,Lifeng Ding,Wu Luo,Xianjiong Chen,Yi Lu,Ziwei Zhu,Xinyu Zhao,Zhifan Ding,Liqun Xia,Qi Liu
出处
期刊:Cancer Research
[American Association for Cancer Research]
日期:2025-07-29
卷期号:85 (20): 4018-4035
被引量:1
标识
DOI:10.1158/0008-5472.can-24-4250
摘要
A causal inference framework based on m6A modifications that quantifies driving effects and characterizes high-benefit tumor profiles offers an improved approach for guiding personalized tumor treatment decisions. This article is part of a special series: Driving Cancer Discoveries with Computational Research, Data Science, and Machine Learning/AI .
科研通智能强力驱动
Strongly Powered by AbleSci AI